Cancer genome study reveals big window for early detection

Tell-tale DNA errors arise years before tumors become dangerous. For cancers that can’t currently be detected early, a new discovery suggests there may be a large window of time in which to look...

Bringing together the leaders in cancer early detection

The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...

Oregon’s colonoscopy trailblazer steps into new leadership role

Colorectal screening, primarily by colonoscopy, contributed to a steep drop in cancer incidence (Yang et al. 2014). David Lieberman, M.D., professor and head of gastroenterology and hepatology in...

Making sense of colorectal cancer screening choices

Colorectal cancer is the third most common cause of cancer death among men and women in the U.S. But there is shockingly large regional variation in mortality, in part because of sharp differences...

Clearing the quandary of cancer early detection

For many cancers, five-year survival rates approach 99 percent if the disease is detected early, when tumors are small and not yet spreading. But efforts to detect cancers early have led to a...

New funding for a dire need: Pancreas cancer early detection

With a $250,000 award from the Pancreatic Cancer Action Network, researchers will seek to validate biomarkers able to detect pancreas cancer months or years before patients experience overt symptoms...

Mole Mapper brings open data for cancer research

A new report in Nature Scientific Data explains how researchers can access and use the growing trove of data coming from users of Mole Mapper, a mobile app for tracking suspicious...

First in philanthropy: Phil and Penny Knight

Phil Knight and Brian Druker, M.D., on "Good Morning America" in 2015. Nike co-founder Phil Knight and his wife Penny ranked no. 1 in The Chronicle of Philanthropy list of Americans who donated...